Warning: The NCBI web site requires JavaScript to function. more...
Estrogen and progesterone induce persistent increases in p53-dependent apoptosis and suppress mammary tumors in BALB/c-Trp53+/- mice.
Dunphy KA, Blackburn AC, Yan H, O'Connell LR, Jerry DJ.
Breast Cancer Res. 2008;10(3):R43. Epub 2008 May 12.
Related citations
Estrogen and progesterone regulate radiation-induced p53 activity in mammary epithelium through TGF-beta-dependent pathways.
Becker KA, Lu S, Dickinson ES, Dunphy KA, Mathews L, Schneider SS, Jerry DJ.
Oncogene. 2005 Sep 22;24(42):6345-53.
Hormone dependence in premalignant mammary progression.
Medina D, Kittrell FS, Shepard A, Contreras A, Rosen JM, Lydon J.
Cancer Res. 2003 Mar 1;63(5):1067-72.
Pathways contributing to development of spontaneous mammary tumors in BALB/c-Trp53+/- mice.
Yan H, Blackburn AC, McLary SC, Tao L, Roberts AL, Xavier EA, Dickinson ES, Seo JH, Arenas RB, Otis CN, Cao QJ, Lawlor RG, Osborne BA, Kittrell FS, Medina D, Jerry DJ.
Am J Pathol. 2010 Mar;176(3):1421-32. Epub 2010 Jan 28.
Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.
Blackburn AC, McLary SC, Naeem R, Luszcz J, Stockton DW, Donehower LA, Mohammed M, Mailhes JB, Soferr T, Naber SP, Otis CN, Jerry DJ.
Cancer Res. 2004 Aug 1;64(15):5140-7.
Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice.
Backlund MG, Trasti SL, Backlund DC, Cressman VL, Godfrey V, Koller BH.
Cancer Res. 2001 Sep 1;61(17):6577-82.
Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome.
Kuperwasser C, Hurlbut GD, Kittrell FS, Dickinson ES, Laucirica R, Medina D, Naber SP, Jerry DJ.
Am J Pathol. 2000 Dec;157(6):2151-9.
p21, p27 and p53 in estrogen and antiprogestin-induced tumor regression of experimental mouse mammary ductal carcinomas.
Vanzulli S, Efeyan A, Benavides F, Helguero LA, Peters G, Shen J, Conti CJ, Lanari C, Molinolo A.
Carcinogenesis. 2002 May;23(5):749-58.
Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models.
Rajkumar L, Kittrell FS, Guzman RC, Brown PH, Nandi S, Medina D.
Breast Cancer Res. 2007;9(1):R12.
Epithelial cell cycling predicts p53 responsiveness to gamma-irradiation during post-natal mammary gland development.
Minter LM, Dickinson ES, Naber SP, Jerry DJ.
Development. 2002 Jun;129(12):2997-3008.
Repression of mammary stem/progenitor cells by p53 is mediated by Notch and separable from apoptotic activity.
Tao L, Roberts AL, Dunphy KA, Bigelow C, Yan H, Jerry DJ.
Stem Cells. 2011 Jan;29(1):119-27. doi: 10.1002/stem.552.
p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis.
Sivaraman L, Conneely OM, Medina D, O'Malley BW.
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12379-84. Epub 2001 Oct 16.
Association of estrogen receptor-alpha and progesterone receptor A expression with hormonal mammary carcinogenesis: role of the host microenvironment.
Montero Girard G, Vanzulli SI, Cerliani JP, Bottino MC, Bolado J, Vela J, Becu-Villalobos D, Benavides F, Gutkind S, Patel V, Molinolo A, Lanari C.
Breast Cancer Res. 2007;9(2):R22.
Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
Bustuoabad OD, di Gianni PD, Franco M, Kordon EC, Vanzulli SI, Meiss RP, Grion LC, Díaz GS, Nosetto SH, Hockl P, Lombardi MG, Pasqualini CD, Ruggiero RA.
Oncol Res. 2002;13(3):147-60.
Hormone-induced chromosomal instability in p53-null mammary epithelium.
Pati D, Haddad BR, Haegele A, Thompson H, Kittrell FS, Shepard A, Montagna C, Zhang N, Ge G, Otta SK, McCarthy M, Ullrich RL, Medina D.
Cancer Res. 2004 Aug 15;64(16):5608-16.
Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcinogenesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-alpha activation via the mitogen-activated protein kinase pathway.
Thordarson G, Slusher N, Leong H, Ochoa D, Rajkumar L, Guzman R, Nandi S, Talamantes F.
Breast Cancer Res. 2004;6(4):R423-36. Epub 2004 Jun 4.
Regression of progestin-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors in Sprague-Dawley rats by p53 reactivation and induction of massive apoptosis: a pilot study.
Benakanakere I, Besch-Williford C, Ellersieck MR, Hyder SM.
Endocr Relat Cancer. 2009 Mar;16(1):85-98. Epub 2008 Dec 15.
Tamoxifen inhibition of estrogen receptor-alpha-negative mouse mammary tumorigenesis.
Medina D, Kittrell FS, Hill J, Shepard A, Thordarson G, Brown P.
Cancer Res. 2005 Apr 15;65(8):3493-6.
A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development.
Jerry DJ, Kittrell FS, Kuperwasser C, Laucirica R, Dickinson ES, Bonilla PJ, Butel JS, Medina D.
Oncogene. 2000 Feb 21;19(8):1052-8.
BALB/c alleles for Prkdc and Cdkn2a interact to modify tumor susceptibility in Trp53+/- mice.
Blackburn AC, Brown JS, Naber SP, Otis CN, Wood JT, Jerry DJ.
Cancer Res. 2003 May 15;63(10):2364-8.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on